These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34146842)

  • 21. Association of vitamin D deficiency with COVID-19 infection severity: Systematic review and meta-analysis.
    Wang Z; Joshi A; Leopold K; Jackson S; Christensen S; Nayfeh T; Mohammed K; Creo A; Tebben P; Kumar S
    Clin Endocrinol (Oxf); 2022 Mar; 96(3):281-287. PubMed ID: 34160843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results.
    D'Ascanio L; Vitelli F; Cingolani C; Maranzano M; Brenner MJ; Di Stadio A
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4156-4162. PubMed ID: 34156697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options.
    Dyavar SR; Singh R; Emani R; Pawar GP; Chaudhari VD; Podany AT; Avedissian SN; Fletcher CV; Salunke DB
    Biomed Pharmacother; 2021 Sep; 141():111794. PubMed ID: 34153851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study.
    Inciarte A; Cardozo C; Chumbita M; Alcubilla P; Torres B; González Cordón A; Rico V; Aguero D; García-Pouton N; Hernández-Meneses M; Albiach L; Meira F; De la Mora L; Linares L; Puerta-Alcalde P; Macaya I; Mensa J; Laguno M; Ambrosioni J; Ramos A; Morata L; Bodro M; Moreno-García E; Moreno A; Sola M; Rojas J; Leal L; Torres M; Garcia-Vidal C; Martínez JA; Alobid I; Soriano A; Garcia F
    BMJ Open; 2021 Aug; 11(8):e040775. PubMed ID: 34404693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mechanisms of smell loss after SARS-CoV-2 infection.
    Doty RL
    Lancet Neurol; 2021 Sep; 20(9):693-695. PubMed ID: 34339627
    [No Abstract]   [Full Text] [Related]  

  • 26. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
    O'Byrne L; Webster KE; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013876. PubMed ID: 34291813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear factor-kappa B and its role in inflammatory lung disease.
    Alharbi KS; Fuloria NK; Fuloria S; Rahman SB; Al-Malki WH; Javed Shaikh MA; Thangavelu L; Singh SK; Rama Raju Allam VS; Jha NK; Chellappan DK; Dua K; Gupta G
    Chem Biol Interact; 2021 Aug; 345():109568. PubMed ID: 34181887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ivermectin for the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Roman YM; Burela PA; Pasupuleti V; Piscoya A; Vidal JE; Hernandez AV
    Clin Infect Dis; 2022 Mar; 74(6):1022-1029. PubMed ID: 34181716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
    Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.
    Schwabenland M; Salié H; Tanevski J; Killmer S; Lago MS; Schlaak AE; Mayer L; Matschke J; Püschel K; Fitzek A; Ondruschka B; Mei HE; Boettler T; Neumann-Haefelin C; Hofmann M; Breithaupt A; Genc N; Stadelmann C; Saez-Rodriguez J; Bronsert P; Knobeloch KP; Blank T; Thimme R; Glatzel M; Prinz M; Bengsch B
    Immunity; 2021 Jul; 54(7):1594-1610.e11. PubMed ID: 34174183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Could the oral cavity be a target organ in SARS-CoV-2 infection?
    Kumar S
    Evid Based Dent; 2021 Jan; 22(2):78-79. PubMed ID: 34172916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.
    Chow R; Im J; Chiu N; Chiu L; Aggarwal R; Lee J; Choi YG; Prsic EH; Shin HJ
    PLoS One; 2021; 16(6):e0253576. PubMed ID: 34166458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis.
    Pal R; Banerjee M; Bhadada SK; Shetty AJ; Singh B; Vyas A
    J Endocrinol Invest; 2022 Jan; 45(1):53-68. PubMed ID: 34165766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study.
    Goudouris ES; Pinto-Mariz F; Mendonça LO; Aranda CS; Guimarães RR; Kokron C; Barros MT; Anísio F; Alonso MLO; Marcelino F; Valle SOR; Junior SD; Barreto IDP; Ferreira JFS; Roxo-Junior P; do Rego Silva AM; Campinhos FL; Bonfim C; Loth G; Fernandes JF; Garcia JL; Capelo A; Takano OA; Nadaf MIV; Toledo EC; Cunha LAO; Di Gesu RSW; Schidlowski L; Fillipo P; Bichuetti-Silva DC; Soldateli G; Ferraroni NR; de Oliveira Dantas E; Pestana S; Mansour E; Ulaf RG; Prando C; Condino-Neto A; Grumach AS
    J Clin Immunol; 2021 Oct; 41(7):1479-1489. PubMed ID: 34164762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 Variants and Vaccines.
    Krause PR; Fleming TR; Longini IM; Peto R; Briand S; Heymann DL; Beral V; Snape MD; Rees H; Ropero AM; Balicer RD; Cramer JP; Muñoz-Fontela C; Gruber M; Gaspar R; Singh JA; Subbarao K; Van Kerkhove MD; Swaminathan S; Ryan MJ; Henao-Restrepo AM
    N Engl J Med; 2021 Jul; 385(2):179-186. PubMed ID: 34161052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Micronutrient therapy and effective immune response: a promising approach for management of COVID-19.
    Lotfi F; Akbarzadeh-Khiavi M; Lotfi Z; Rahbarnia L; Safary A; Zarredar H; Baghbanzadeh A; Naghili B; Baradaran B
    Infection; 2021 Dec; 49(6):1133-1147. PubMed ID: 34160789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulation of brain and choroid plexus cell types in severe COVID-19.
    Yang AC; Kern F; Losada PM; Agam MR; Maat CA; Schmartz GP; Fehlmann T; Stein JA; Schaum N; Lee DP; Calcuttawala K; Vest RT; Berdnik D; Lu N; Hahn O; Gate D; McNerney MW; Channappa D; Cobos I; Ludwig N; Schulz-Schaeffer WJ; Keller A; Wyss-Coray T
    Nature; 2021 Jul; 595(7868):565-571. PubMed ID: 34153974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential biomarkers for the early prediction of SARS-COV-2 disease outcome.
    Mariappan V; Manoharan PS; R P; Shanmugam L; Rao SR; Pillai AB
    Microb Pathog; 2021 Sep; 158():105057. PubMed ID: 34153419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronaviruses, cholesterol and statins: Involvement and application for Covid-19.
    Orlowski S; Mourad JJ; Gallo A; Bruckert E
    Biochimie; 2021 Oct; 189():51-64. PubMed ID: 34153377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19.
    Touyz RM; Boyd MOE; Guzik T; Padmanabhan S; McCallum L; Delles C; Mark PB; Petrie JR; Rios F; Montezano AC; Sykes R; Berry C
    CJC Open; 2021 Oct; 3(10):1257-1272. PubMed ID: 34151246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.